What is Align Technology Inc?
provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.
ALGN · Verdict
Solid reward · moderate risk
ALGN stands out on balance sheet and cash flow, but watch the volatility signal.
Based on 88% data coverage
ALGN · Verdict
Current ratio 1.36
12% free-cash-flow margin
P/E 15.7× · PEG 0.94
Weak vs peers
Model-based scoring. For information only — not financial advice.
provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 12.78B, and a P/E ratio of 29.9x.
The scoring profile indicates moderate reward potential, with valuation and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.